Product
FLT190
2 clinical trials
2 indications
Indication
Fabry DiseaseIndication
Lysosomal Storage DiseasesClinical trial
A Phase 1/2, Baseline-controlled, Non-randomized, Open-label, Single-ascending Dose Study of a Novel Adeno-associated Viral Vector (FLT190) in Patients With Fabry DiseaseStatus: Terminated, Estimated PCD: 2023-05-02
Clinical trial
A Multicenter, Long-term, Follow-up Study to Investigate the Safety and Durability of Response Following Dosing of an Adeno-associated Viral Vector (FLT190) in Subjects With Fabry DiseaseStatus: Completed, Estimated PCD: 2023-09-28